Drug intelligence / Profile preview

NM-05

Development stage
Unknown
Lead developer
Full-Life Technologies
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

NM-05 is a radiopharmaceutical comprising a camelid-derived single-domain antibody (sdAb) designed to target Fibroblast Activation Protein (FAP). FAP is a cell-surface glycoprotein significantly overexpressed in cancer-associated fibroblasts (CAFs) within the stroma of most epithelial tumors, while showing low expression in healthy adult tissues. This differential expression makes NM-05 a promising candidate for pan-cancer imaging and therapy. Originally developed by NanoMab Technology, the global intellectual property rights for NM-05 were licensed to Full-Life Technologies for further clinical development.

02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on NM-05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NM-05.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call